Evidence map›Paper›PMID 37526476›Full record

ArticlemBio2023

Pathogen-specific structural features of

José A Manso, Arturo Carabias, Zsuzsa Sárkány, José M de Pereda, Pedro José Barbosa Pereira, Sandra Macedo-Ribeiro

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

José A MansoIBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto , Porto, Portugal.ORCID 0000-0002-2565-6239
Arturo CarabiasInstituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas-University of Salamanca , Salamanca, Spain.ORCID 0000-0001-6286-2309
Zsuzsa SárkányIBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto , Porto, Portugal.ORCID 0000-0001-9185-8210
José M de PeredaInstituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas-University of Salamanca , Salamanca, Spain.ORCID 0000-0002-8912-6739
Pedro José Barbosa PereiraIBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto , Porto, Portugal.ORCID 0000-0003-0969-5438
Sandra Macedo-RibeiroIBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto , Porto, Portugal.ORCID 0000-0002-7698-1170
Universidade do Porto · PTConsejo Superior de Investigaciones Científicas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An important feature associated with

Indexed as

Candida albicansCandidiasisAntifungal AgentsFungal ProteinsGuanine Nucleotide Exchange FactorsHumansHyphaeSignal TransductionAntifungal AgentsFungal ProteinsGuanine Nucleotide Exchange Factorscell division control protein 25polyQRas-like protein 1small angle X-ray scatteringX-ray crystallography

Identifiers

PMID37526476
PMCPMC10470544
OpenAlexW4385442401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.